Gentamicin Sulfate, Injectable

DRUG2 trials

Sponsors

Public Health Service of Amsterdam, University of Southern California

Conditions

GonorrheaJunctional Epidermolysis Bullosa

Phase 1

Optimizing IV Gentamicin in JEB

University of Southern CaliforniaJunctional Epidermolysis Bullosa

Start: 2019-10-31End: 2023-11-01Target: 6Updated: 2022-11-03

Phase 3

New AntiBiotic Treatment Options for Uncomplicated Anogenital GOnorrhoea

CompletedNCT03294395

Public Health Service of AmsterdamGonorrhea

Start: 2017-09-18End: 2020-06-05Updated: 2021-08-06

Related Papers

Diarrhoea as a frequent adverse event after intramuscular ertapenem treatment for uncomplicated <i>Neisseria gonorrhoeae</i>: a secondary analysis from the NABOGO trial.

2026-01-16

Spontaneous clearance of asymptomatic anogenital and pharyngeal <i>Neisseria gonorrhoeae</i>: a secondary analysis from the NABOGO trial

Sexually Transmitted Infections2022-07-1210 citations

Molecular and Clinical Outcomes After Intravenous Gentamicin Treatment for Patients With Junctional Epidermolysis Bullosa Caused by Nonsense Variants

JAMA Dermatology2022-03-0225 citations

Efficacy of ertapenem, gentamicin, fosfomycin, and ceftriaxone for the treatment of anogenital gonorrhoea (NABOGO): a randomised, non-inferiority trial.

2022-01-1935 citations